QuiaPEG Pharmaceuticals Holding AB (99B0) Stock Statistics & Valuation Metrics

QuiaPEG Pharmaceuticals Holding AB has a market cap or net worth of $586.12K. The enterprise value is ―.

QuiaPEG Pharmaceuticals Holding AB has 2,124,285,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

QuiaPEG Pharmaceuticals Holding AB’s return on equity (ROE) is -1.77 and return on invested capital (ROIC) is -170.08%.

The current PE Ratio of QuiaPEG Pharmaceuticals Holding AB is ―. QuiaPEG Pharmaceuticals Holding AB’s PEG ratio is 0.00205.

In the last 12 months, QuiaPEG Pharmaceuticals Holding AB had revenue of 460.00K and earned -28.93M in profits. Earnings per share was -0.08.

In the last 12 months, operating cash flow was -7.54M and capital expenditures 0.00, giving a free cash flow of -7.54M billion.

QuiaPEG Pharmaceuticals Holding AB pays an annual dividend of ―, resulting in a dividend yield of ―

QuiaPEG Pharmaceuticals Holding AB upcoming earnings date is Aug 27, 2026, TBA (Confirmed).

QuiaPEG Pharmaceuticals Holding AB as a current ratio of 0.16, with Debt / Equity ratio of 0.00%

In the past 12 months, QuiaPEG Pharmaceuticals Holding AB has paid 0.00 in taxes.

QuiaPEG Pharmaceuticals Holding AB EV to EBITDA ratio is -0.44, with an EV/FCF ratio of -0.40.

QuiaPEG Pharmaceuticals Holding AB has $4.00K in cash and marketable securities with $0.00 in debt, giving a net cash position of $4.00K billion.

Gross margin is 95.93%, with operating margin of -6231.52%, and net profit margin of -6288.91%.

The average price target for QuiaPEG Pharmaceuticals Holding AB is ―, which is 11.43% higher than the current price. The consensus rating is ―